Schedule 13D ownership disclosure
Regencell Bioscience Holdings Ltd.
Ordinary Shares, $0.00001 Par Value · CUSIP: G7487R100
Event date: 2025-03-10
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Regencell (BVI) LimitedReported CIK 0001874958
Shares: 11,221,821.00 · Class: 86.2%
- Yat-Gai Au
Shares: 11,221,821.00 · Class: 86.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-023407
- Form type
- SCHEDULE 13D/A
- Filer
- Regencell (BVI) Ltd
- CIK
- CIK 1874958
- Filed
- Mar 13, 2025
- Reporting period
- Mar 10, 2025
- Description
- Schedule 13D beneficial ownership